Ambrosan, tablets 30 mg, 20 pcs.

Ambrosan is secretomotor, antitussive, mucolytic, expectorant.

Stimulates serous cells of bronchial mucous membrane glands (restores the disturbed ratio of serous and mucous components of sputum), activates hydrolases, liquefies sputum, reduces its viscosity and facilitates excretion, increases mucociliary clearance. It improves lung ventilation and reduces coughing.

Pharmacokinetics

It is quickly and completely absorbed when taken orally. C_max in plasma is reached after 0.5-3 hours. It penetrates well into the bronchial mucosa and lung tissue. T_1/2 is 7-12 hours. It is excreted mainly by the kidneys.

Indications

Colds, Respiratory tract infections, Bronchial asthma, Lung inflammation (pneumonia), Cough, Chronic obstructive pulmonary disease, Bronchitis

Infectious and inflammatory diseases of the bronchopulmonary system, accompanied by the formation of sputum difficult to separate: Acute bronchitis, tracheitis, chronic bronchitis in the acute stage, chronic obstructive pulmonary disease, bronchial asthma, bronchopneumonia, cystic fibrosis, bronchiectatic disease; prevention of congestion in the bronchopulmonary system after major surgical interventions, injuries.

Active ingredient

Ambroxol

Composition

1 tablet contains:

Active substance:

ambroxol hydrochloride 30 mg;

Associates:

Microcrystalline granulated cellulose,

lactose monohydrate,

magnesium stearate,

copovidone.